Texas Bans Hemp in 3 Days, Georgia Expands It, and Virginia Finally Opens the Door

The Weedcoin Team

Three states, three directions -- and the clock is ticking on all of them.

Three days from now, the Texas hemp market as we know it ends. On the same week, Georgia lawmakers voted overwhelmingly to expand medical cannabis access. And Virginia -- five years after legalizing possession -- finally approved retail sales.


Cannabis policy in 2026 is not one story. It is dozens of stories happening simultaneously, pulling in opposite directions, often within the same week. What ties them together is a simple truth: the old framework is breaking apart, and nobody agrees on what replaces it.


Let's get into it.


Texas: Three Days Until the Hammer Drops


On March 31, new rules from the Texas Department of State Health Services take effect with no grace period. The changes are sweeping, and the hemp industry in the state is scrambling.


The biggest hit: THCA flower is effectively banned. Under the new rules, THCA will be included in total THC calculations, which means that hemp flower products containing significant levels of THCA -- the precursor compound that converts to THC when heated -- will exceed the 0.3 percent total THC threshold and become illegal to sell.


The rules also impose a 21-and-older purchase requirement for all consumable hemp products, mandate valid ID checks at point of sale, and introduce updated packaging and testing standards. Perhaps most critically, licensing fees are jumping dramatically, putting smaller operators at risk of being priced out.


Texas received over 1,400 public comments during the rulemaking process and held public hearings before finalizing the rules. The proposed rules were published for adoption in the March 20 Texas Register, giving businesses barely ten days to comply.


For a state with one of the largest hemp markets in the country, the speed and severity of the rollout is striking. Businesses that built their operations around THCA flower products now have three days to pivot or shut down.


This is not an isolated event. Ohio recently banned most hemp-derived THC products after a failed referendum to block the ban. New Jersey's 90-day grace period on its own hemp restrictions ends April 13. Las Vegas adopted an ordinance banning hemp THC products effective July 15. And at the federal level, the Farm Bill's November deadline to recriminalize intoxicating hemp products looms over everything.


The hemp industry is watching dominoes fall -- and Texas is the next one.


Georgia: From 5 Percent to Full Strength


While Texas is closing doors, Georgia is opening them wider than they have ever been.


The Georgia House of Representatives voted 144-21 to approve Senate Bill 220, the Putting Georgia's Patients First Act. The bill now sits on Governor Brian Kemp's desk.


If signed, the changes would be transformative. The current 5 percent THC cap on medical cannabis products would be eliminated entirely, replaced by a possession limit of 12,000 milligrams of THC at any one time. The product category would be renamed from "Low THC Oil" to "medical cannabis." And for the first time, patients 21 and older would be allowed to vape medical cannabis for faster relief.


The bill also expands qualifying conditions by adding lupus, severe arthritis, and severe insomnia to the existing list, which already includes seizure disorders, Parkinson's disease, multiple sclerosis, and post-traumatic stress disorder. Language restricting many conditions to "severe" or "end-of-life" cases would be removed.


Georgia would become the 41st state to specifically authorize cannabis for medical purposes. The drug remains illegal for recreational use.


The 144-21 vote margin says something. This is not a close call. Georgia lawmakers looked at the evidence, talked to patients, and decided that a 5 percent THC cap was not serving anyone except the illicit market.


Virginia: Five Years of Waiting, One Bill to End It


Virginia legalized cannabis possession in 2021. Five years later, there are still no legal retail stores.


That changes now. The Virginia General Assembly passed legislation initiating retail cannabis sales on January 1, 2027, with a sales tax capped below 15 percent. Governor Abigail Spanberger, who has expressed support for regulated sales, is expected to sign the bills.


The delay was political. After Virginia legalized possession, Republicans gained control of the House and the governorship in 2022 and refused to advance retail legislation. During that time, the illicit market exploded. As NORML's JM Pedini put it: "The illicit market exploded during Youngkin's term."


The new legislation puts cannabis sales behind age-verified dispensary counters, introduces testing and labeling standards, and reinvests tax revenue into Virginia communities. It is the culmination of years of advocacy and a clear signal that legalization without regulation creates more problems than it solves.

Medical researcher examining brain scan data and epilepsy seizure patterns on a monitor

Cannabis and Epilepsy: When Seizure Freedom Is the Goal


Today's cannabis benefits deep dive is on epilepsy and seizure disorders -- one of the areas where the scientific evidence is strongest and the human impact is most dramatic.


A case series published in Frontiers in Neuroscience documented 19 patients with drug-resistant epilepsy who achieved complete seizure freedom using medical cannabis oil containing CBD and THC. These were patients for whom conventional anti-seizure medications had failed. The patients spent approximately 50 percent of their total treatment duration seizure-free, starting from a median pre-treatment rate of 6.5 seizures per month.


That finding matters because seizure freedom is the primary treatment goal in epilepsy care, and it becomes increasingly difficult to achieve with each successive medication tried. Research shows that after the first anti-seizure medication fails, each additional regimen provides diminishing returns -- just 11.6 percent additional likelihood of seizure freedom with the second, and 4.4 percent with the third.


The FDA has already approved Epidiolex, a pharmaceutical-grade CBD product, for severe pediatric seizure disorders including Dravet syndrome and Lennox-Gastaut syndrome. But the emerging research suggests that combinations of CBD and THC may offer broader benefits than CBD alone. CBD-rich extracts have demonstrated similar degrees of seizure reduction compared to purified CBD, and clinical reports show that adding THC may contribute to achieving seizure freedom in pediatric patients with drug-resistant epilepsy.


In the UK, two national NHS clinical trials are now investigating CBD and CBD-plus-THC formulations in 500 adults and children with treatment-resistant epilepsy. These are the first double-blind randomized controlled trials to evaluate CBD and THC together for epilepsy, and the first to evaluate these medicines across a broad range of difficult-to-treat epilepsy types.


For families living with uncontrolled seizures, this research is not academic. It is hope with data behind it.


The Munchies Are Real -- and Medically Useful


A collaborative study from Washington State University and the University of Calgary, published in the Proceedings of the National Academy of Sciences, confirmed what cannabis users have always known: the munchies are real.


The study found that THC stimulates cannabinoid receptors in the brain to create feelings of hunger regardless of sex, age, weight, or recent food consumption. Crucially, blocking those receptors in the brain eliminated the effect, while blocking them in the peripheral nervous system did not -- confirming that the appetite response is brain-mediated, not gut-mediated.


This matters far beyond recreational use. Wasting syndromes and appetite loss affect patients with HIV/AIDS, cancer patients on chemotherapy, and people with various chronic conditions. Understanding the mechanism behind cannabis-induced appetite gives researchers a clearer pathway to developing targeted treatments for people who desperately need to eat but cannot.


Solana: Building Through Consolidation


In crypto, Solana is navigating a correction after testing highs near $220 in February. SOL pulled back through March and currently sits around $87, with key support at the $80 level. The broader market correction has tested every chain, but Solana's on-chain fundamentals remain strong -- daily active users continue at high levels across DeFi, NFTs, and the meme coin ecosystem.


Two major upgrades are in focus. The Firedancer validator client, developed by Jump Crypto, has been adopted by a significant portion of validators, improving network throughput and reducing outage risk. And the Alpenglow upgrade -- Solana's most ambitious consensus overhaul targeting sub-second finality -- is aiming for mainnet deployment.


Analyst forecasts for year-end range from bearish targets around $120-$150 to consensus projections of $250-$300, with bulls calling for $350-$400 if the breakout materializes. For Weedcoin, the key is that Solana's infrastructure continues to strengthen regardless of short-term price action.


Where We Stand


Twenty-three days to 4/20. Four days to Weedcoin's one-year anniversary on April 1.


Texas is shutting doors. Georgia is opening them. Virginia is finally building the rooms. The epilepsy data is stacking up. The science behind appetite is getting clearer. And the network underneath Weedcoin keeps getting stronger.


Three directions. One trajectory. Forward.


Stay connected with the Weedcoin OG community:


Website: https://www.weedcoinog.com

Follow us on X: https://x.com/weedcoinog

Chat With Wiz (GPT): https://bit.ly/ChatWithWeedcoin

Contract Address: 21nnfR4TkbZNLwvRrqEseAbz7P3kxKjaV7KuboLJpump


Like bitcoin but way higher

U.S. Army recruitment office with cannabis reform documents and American flag in the background
By The Weedcoin Team March 27, 2026
The U.S. Army scraps marijuana waivers effective 4/20, the FDA submits its first CBD enforcement policy, and Medicare prepares to cover hemp-derived CBD for seniors.
Supreme Court building at golden hour with cannabis plant growing from marble steps
By The Weedcoin Team March 26, 2026
The Supreme Court questions the cannabis gun ban while the IRS digs in on 280E. Texas hemp ban hits March 31. New research shows cannabinoids improve sleep quality.
Hemp flower and gavel on Texas flag representing the March 31 smokeable hemp ban and cannabis policy
By The Weedcoin Team March 25, 2026
Texas bans smokeable hemp products March 31. Meanwhile, Big Alcohol is pushing Congress to regulate hemp THC beverages — not ban them. Here's what it means.
Cannabis plant under microscope lens in research lab with medical journals and warm lighting
By The Weedcoin Team March 24, 2026
A massive Lancet study says cannabis doesn't treat anxiety or PTSD — but the full picture is way more complicated. Here's what the science actually shows in 2026.
Woodcut print of the US Capitol surrounded by cannabis leaves with a stock ticker ribbon showing gre
By The Weedcoin Team March 23, 2026
A bipartisan bill would let cannabis companies list on Nasdaq and NYSE. Medicare is about to cover CBD. Virginia is days from retail. The feds have not moved.
Dimly lit cannabis dispensary storefront at night with green neon glow and St. Patrick's Day signage
By The Weedcoin Team March 17, 2026
On St. Patrick's Day 2026, the real green is still under fire. Cannabis reform battles rage across the country while Weedcoin OG holds the culture together.
By The Weedcoin Team March 16, 2026
The Senate stripped anti-rescheduling language from the federal spending bill while the Supreme Court questioned cannabis prohibition logic. The culture is winning.
By The Weedcoin Team March 15, 2026
States are pushing cannabis reform in 2026, but prohibitionists are fighting back. Here's the full picture — and why the conversation has never mattered more.
Hyperrealism illustration of crypto charts with Hidden Order Blocks as metallic vaults in Fair Value
By The Weedcoin Team July 14, 2025
Dive into Hidden Order Blocks with ICT, LuxAlgo, Mind Math Money, and Arva Forum insights: Mechanics, identification, strategies, and confluence tools for crypto trading. Enhance your SMC edge—join Weedcoin’s Green Candle Sesh tonight.
Ethereal crossroads of crypto surges and cannabis policies in data-weaving abstraction, symbolizing
By The Weedcoin Team July 12, 2025
Dive into July 2025’s crypto highs like Bitcoin ATHs and Cannabis Week, plus legalization pushes in PA and beyond. Weedcoin’s take on cultural growth.
Wiz, Haze, and Quakk’s duck host an open mic on a neon stage above glowing wetlands at sunset.
By The Weedcoin Team July 9, 2025
Builders grab the mic! Dive into Quakk’s vision for Web3 hubs, NFTs, and wetland restoration. Where culture, creativity, and conservation collide on Solana.
A neon arena on Solana’s blockchain where digital coins rise and fall amid a crowd of meme traders.
By The Weedcoin Team July 8, 2025
The Arena of Instant Tokens
More Posts